Cargando…
High Expression of DC-STAMP Gene Predicts Adverse Outcomes in AML
Acute myeloid leukemia (AML) is a genetically heterogeneous hematological malignancy with poor prognosis. We explored the RNA sequence data and clinical information of AML patients from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) database to search for the core molecule for...
Autores principales: | Liang, Qian, Zhang, Lele, Wang, Wenjun, Zhao, Jingyu, Li, Qiaoli, Pan, Hong, Gao, Zhen, Fang, Liwei, Shi, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091727/ https://www.ncbi.nlm.nih.gov/pubmed/35571050 http://dx.doi.org/10.3389/fgene.2022.876689 |
Ejemplares similares
-
High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia
por: Li, Qiaoli, et al.
Publicado: (2023) -
Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia
por: Wang, Wenjun, et al.
Publicado: (2022) -
P582: AZACITIDINE COMBINED WITH HAG REGIMEN AS INDUCTION THERAPY IN ADULT AML PATIENTS
por: Pan, Hong, et al.
Publicado: (2023) -
RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
por: Kukita, Toshio, et al.
Publicado: (2004) -
Characterization of DC-STAMP+ Cells in Human Bone Marrow
por: Chiu, Yahui Grace, et al.
Publicado: (2013)